Sorafenib
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00398 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 12 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | clear cell renal carcinoma | TxGNN Knowledge Graph |
| 2 | fibrolamellar hepatocellular carcinoma | TxGNN Knowledge Graph |
| 3 | undifferentiated carcinoma of liver and intrahepatic biliary tract | TxGNN Knowledge Graph |
| 4 | squamous cell carcinoma of liver and intrahepatic biliary tract | TxGNN Knowledge Graph |
| 5 | nonpapillary renal cell carcinoma | TxGNN Knowledge Graph |
| 6 | thyroid gland carcinoma | TxGNN Knowledge Graph |
| 7 | pediatric hepatocellular carcinoma | TxGNN Knowledge Graph |
| 8 | liver cancer | TxGNN Knowledge Graph |
| 9 | hepatocellular carcinoma | TxGNN Knowledge Graph |
| 10 | renal cell carcinoma (disease) | TxGNN Knowledge Graph |
| 11 | adenocarcinoma of liver and intrahepatic biliary tract | TxGNN Knowledge Graph |
| 12 | renal cell adenocarcinoma | TxGNN Knowledge Graph |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.